Casein Kinase inhibitor A51
4-N-[5-chloro-4-[5-(cyclopropylmethyl)-1-methylpyrazol-4-yl]pyrimidin-2-yl]cyclohexane-1,4-diamine
Molecular Identity
Casein Kinase inhibitor A51
4-N-[5-chloro-4-[5-(cyclopropylmethyl)-1-methylpyrazol-4-yl]pyrimidin-2-yl]cyclohexane-1,4-diamine
PubChem CID: 126558497
2D Structure
Properties
C18H25ClN6
Molecular Formula
360.90
Molecular Weight
g/mol
360.1829
Exact Mass
Da
2.9
XLogP
Drug-like (Lipinski: < 5)
81.7
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
5
H-Bond Acceptors
439
Complexity
SMILES
Canonical SMILES
SMILES: CN1C(=C(C=N1)C2=NC(=NC=C2Cl)NC3CCC(CC3)N)CC4CC4Isomeric SMILES
SMILES: CN1C(=C(C=N1)C2=NC(=NC=C2Cl)NC3CCC(CC3)N)CC4CC4Synonyms(20)
Casein Kinase inhibitor A512079068-74-7BTX-A51trans-N1-(5-Chloro-4-(5-(cyclopropylmethyl)-1-methyl-1H-pyrazol-4-yl)pyrimidin-2-yl)cyclohexane-1,4-diamineCHEMBL4754493CHEMBL5569495(1R,4r)-N1-(5-chloro-4-(5-(cyclopropylmethyl)-1-methyl-1H-pyrazol-4-yl)pyrimidin-2-yl)cyclohexane-1,4-diamineCasein Kinase inhibitor A51?L46P54NB4Vorb1685312SCHEMBL18480092SCHEMBL20421801SCHEMBL29538940EX-A5483BDBM50553499
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Casein Kinase inhibitor A51
Loading drug network...